immunoglobulin replacement therapy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

84,132 results for “immunoglobulin replacement therapy”

Trials

View all 59367 →

IVIG for Infection Prevention After CAR-T-Cell Therapy

150 participants · First posted Jul 19, 2023

Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis

First posted Nov 9, 2018

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

58 participants · First posted Dec 6, 2023

Drugs

View all 4946 →

Chaperone + RhIDUA Enzyme Replacement Therapy (Amicus Therapeutics)

Hormone replacement therapy(Pharmacia)

Dystrophin replacement therapy(Orna)

Organizations

View all 127 →

COLORADO JOINT REPLACEMENT

United States

Spokane Joint Replacement Center, Inc.

United States

METABOLIC THERAPY, INC.

United States

News

View all 19692 →

Large Real-World Study Questions Effectiveness of Immunoglobulin Replacement Therapy in CLL Patients

Solvent Detergent-Treated IVIG Demonstrates Absence of Hypotensive Effects in Clinical Trials

Takeda Launches GAMMAGARD LIQUID ERC, First Ready-to-Use Low-IgA Immunoglobulin Therapy in U.S.

Page 1 of 8414